| Symbol |
Name |
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
APC
|
adenomatous polyposis coli
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AREG
|
amphiregulin
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BHLHA15
|
basic helix-loop-helix family, member a15
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C17ORF97
|
chromosome 17 open reading frame 97
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CD163
|
CD163 molecule
|
|
CD274
|
CD274 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD68
|
CD68 molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CENPH
|
centromere protein H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CLDN1
|
claudin 1
|
|
CLDN18
|
claudin 18
|
|
CLDN7
|
claudin 7
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
|
COX2
|
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
DCTN6
|
dynactin 6
|
|
DPH1
|
diphthamide biosynthesis 1
|
|
DUOX1
|
dual oxidase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
EREG
|
epiregulin
|
|
ESR1
|
estrogen receptor 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F11R
|
F11 receptor
|
|
FAM3C
|
family with sequence similarity 3, member C
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FN1
|
fibronectin 1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas 1
|
|
GATA3
|
GATA binding protein 3
|
|
GLS
|
glutaminase
|
|
GORASP1
|
golgi reassembly stacking protein 1, 65kDa
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AX
|
H2A.X variant histone
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB3
|
heat shock 27kDa protein 3
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IP6K1
|
inositol hexakisphosphate kinase 1
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT13
|
keratin 13, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT4
|
keratin 4, type II
|
|
LAMC2
|
laminin, gamma 2
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LDHB
|
lactate dehydrogenase B
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B
|
|
LMO4
|
LIM domain only 4
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MRPL28
|
mitochondrial ribosomal protein L28
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NGFR
|
nerve growth factor receptor
|
|
NOTCH1
|
notch 1
|
|
NXT1
|
nuclear transport factor 2-like export factor 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDHX
|
pyruvate dehydrogenase complex, component X
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDXP
|
pyridoxal (pyridoxine, vitamin B6) phosphatase
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLG
|
plasminogen
|
|
PMEL
|
premelanosome protein
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PRL
|
prolactin
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RACK1
|
receptor for activated C kinase 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMAD4
|
SMAD family member 4
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SUB1
|
SUB1 homolog (S. cerevisiae)
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYT1
|
synaptotagmin I
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM3
|
transglutaminase 3
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMED7
|
transmembrane emp24 protein transport domain containing 7
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
|
TNC
|
tenascin C
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VSIR
|
V-set immunoregulatory receptor
|
|
VTN
|
vitronectin
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
ZIC1
|
Zic family member 1
|
